AVITA Medical Inc
NASDAQ:RCEL

Watchlist Manager
AVITA Medical Inc Logo
AVITA Medical Inc
NASDAQ:RCEL
Watchlist
Price: 9 USD -4.05% Market Closed
Market Cap: 237.2m USD
Have any thoughts about
AVITA Medical Inc?
Write Note

Wall Street
Price Targets

RCEL Price Targets Summary
AVITA Medical Inc

Wall Street analysts forecast RCEL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCEL is 17.85 USD with a low forecast of 14.14 USD and a high forecast of 23.1 USD.

Lowest
Price Target
14.14 USD
57% Upside
Average
Price Target
17.85 USD
98% Upside
Highest
Price Target
23.1 USD
157% Upside
AVITA Medical Inc Competitors:
Price Targets
PTCT
PTC Therapeutics Inc
18% Upside
IMAB
I-Mab
591% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
88% Upside
MIRM
Mirum Pharmaceuticals Inc
43% Upside
VICO
Vicore Pharma Holding AB
330% Upside
603087
Gan & Lee Pharmaceuticals
39% Upside
688520
Sinocelltech Group Ltd
72% Upside
BAVA
Bavarian Nordic A/S
79% Upside

Revenue
Forecast

Revenue Estimate
AVITA Medical Inc

For the last 2 years the compound annual growth rate for AVITA Medical Inc's revenue is 37%. The projected CAGR for the next 3 years is 52%.

37%
Past Growth
52%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
AVITA Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
AVITA Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RCEL's stock price target?
Price Target
17.85 USD

According to Wall Street analysts, the average 1-year price target for RCEL is 17.85 USD with a low forecast of 14.14 USD and a high forecast of 23.1 USD.

What is AVITA Medical Inc's Revenue forecast?
Projected CAGR
52%

For the last 2 years the compound annual growth rate for AVITA Medical Inc's revenue is 37%. The projected CAGR for the next 3 years is 52%.

Back to Top